Midway Specialty Care Center

This study follows 100 cisgender women in the southern U.S. who are already using a long-acting injectable medication (cabotegravir) to prevent HIV. Researchers want to see how many women keep up with their shots over 44 weeks and how satisfied they are with the treatment. The go…